Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950103-25-010166
Filing Date
2025-08-12
Accepted
2025-08-12 06:07:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13595
  Complete submission text file 0000950103-25-010166.txt   15473
Mailing Address C/O MAPLES CORPORATE SERVICES LIMITED P.O. BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address C/O MAPLES CORPORATE SERVICES LIMITED P.O. BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 8621-6101-6522
Qiming Venture Partners IV, L.P. (Filed by) CIK: 0001603597 (see all company filings)

EIN.: 981164224 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI China
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI China 862161632588
Zai Lab Ltd (Subject) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90351 | Film No.: 251203908
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)